No products in the cart.
Letrozole (1 mg/60 capsules), 60 mg
Roll over image to zoom in
Click to open expanded view
Letrozole is an aromatase inhibitor approved by the United States Food and Drug Administration (FDA) to treat hormone receptor-positive breast cancers. Compared to Tamoxifen, Letrozole has shown to be more effective as adjuvant treatment for breast cancer.
Tamoxifen, like Letrozole, is used to treat hormonally-responsive malignant breast growth but with interactions with estrogen receptor.
Letrozole is contraindicated in women who are post-menopausal, pregnant, and lactating.
Other Names: 4,4′-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile), CGS 20267, Femara, Femera, Letroze
Total Amount of Active Ingredient: 60 mg,
Concentration: 10 mg per capsule
Quantity: 60 caps
Shelf Life: 36 months
Packaging: capsulated, bottled
Label: 7.5 cm x 2.8 cm
•USA: $6.95 (3-7 business days)
•Canada: $13.95 (3-7 business days)
•International: $18.95 (7-14 business days)
•Europe: $15.95 (7-14 business days)
•South Asia: (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka) $63.95 (7-14 business days) Not available at this time
•Middle Eastern: (Egypt, Bahrain, Cyprus, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, UAE, Yemen, Turkey): $58.95 (7-14 business days)
If your shipment was seized (International Orders), we will provide a 50% discount applicable on your next purchase. Please contact us for more information.
Products are made and housed in the USA and Europe.
All of our products are laboratory tested and the results are periodically published on the website.